11-01-2019
STALICLA is pleased to announce the successful closure of the 2018 tranche of its series A round for a total amount of CHF 10M committed by a consortium of private and Biotech experienced investors
07-01-2019
STALICLA CEO, Lynn Durham presents STALICLA’s most recent biomarker data at the 2nd Annual Neuroscience Innovation Forum in San Francisco
21-11-2018
STALICLA’s CEO & founder’s interview on CNN money.ch from November 21st is available to stream online:
01-11-2018
